The termination is the latest in a series of cuts to H.I.V. research and programs to prevent the disease.

“The consortia for H.I.V./AIDS vaccine development and immunology was reviewed by N.I.H. leadership, which does not support it moving forward,” said a senior official at the National Institutes of Health who was not authorized to speak on the matter and asked not to be identified.

From NYT > Top Stories via this RSS feed